INTC
Intel Hits 1 Million-Wafer Milestone With ASML’s Next-Gen Chip Technology
Intel Hits 1 Million-Wafer Milestone With ASML’s Next-Gen Chip Technology...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
INTC
5 Stock Picks Last Week From Wall Street's Most Accurate Analysts
5 Stock Picks Last Week From Wall Street's Most Accurate Analysts...
BOX
Box CEO Aaron Levie Says 'Best Opportunities' In AI are Products That are 'Barely Only Possible' Today
Box CEO Aaron Levie Says 'Best Opportunities' In AI are Products That are 'Barely Only Possible' Today...
AMGN
Cantor Fitzgerald Reiterates Neutral on Amgen, Maintains $400 Price Target
Cantor Fitzgerald Reiterates Neutral on Amgen, Maintains $400 Price Target...
CVX
Top Economist Slams Trump’s Venezuela Oil Deal ‘Theft’ — ‘Toppled Their Leader’ and ‘Had Him Sign Over Billions’
Top Economist Slams Trump’s Venezuela Oil Deal ‘Theft’ — ‘Toppled Their Leader’ and ‘Had Him Sign Over Billions’...
AAPL
Needham Reiterates Hold on Appleto Hold
Needham Reiterates Hold on Appleto Hold...
BIDU
Novartis, Ionis Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
Novartis, Ionis Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session...
JNJ
Johnson & Johnson To Present Data Across Its Neuropsychiatry Portfolio at 2026 Psych Congress Annual Meeting
Johnson & Johnson To Present Data Across Its Neuropsychiatry Portfolio at 2026 Psych Congress Annual Meeting...
AMGN
BMO Capital Downgrades Amgen to Market Perform, Maintains Price Target to $450
BMO Capital Downgrades Amgen to Market Perform, Maintains Price Target to $450...
VZ
Verizon And Corning Sign Multi-Billion-Dollar Fiber Deal To Expand Broadband And Build AI Infrastructure
Verizon And Corning Sign Multi-Billion-Dollar Fiber Deal To Expand Broadband And Build AI Infrastructure...
AZN
AstraZeneca Says Phase 3 DeLLphi-305 Interim Analysis Showed IMFINZI Plus Amgen's Tarlatamab Met Primary Endpoint With Statistically Significant Overall Survival Improvement vs. IMFINZI Alone In Extensive-Stage Small Cell Lung Cancer
AstraZeneca Says Phase 3 DeLLphi-305 Interim Analysis Showed IMFINZI Plus Amgen's Tarlatamab Met Primary Endpoint With Statistically Significant Overa...
AMGN
This Best Buy Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Tuesday
This Best Buy Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Tuesday...
USO
Hormuz Risk, $100 Oil and 4 ETFs Investors Must Watch
Hormuz Risk, $100 Oil and 4 ETFs Investors Must Watch...
MRK
Guggenheim Maintains Buy on Merck & Co, Raises Price Target to $170
Guggenheim Maintains Buy on Merck & Co, Raises Price Target to $170...
ARM
What's Going On With Arm Holdings Stock Tuesday?
What's Going On With Arm Holdings Stock Tuesday?...
AMGN
Amgen shares are trading lower amid sympathy with Novartis after that company's pelacarsen phase III trial failed to reach its primary endpoint, with investors assessing the impact on AMGN's olpasiran phase III study. Also, BMO Capital downgraded its rating on the stock from Outperform to Market Perform and maintained its $450 price target.
Amgen shares are trading lower amid sympathy with Novartis after that company's pelacarsen phase III trial failed to reach its primary endpoint, with ...
INTC
Roivant Sciences, Pharvaris, IonQ And Other Big Stocks Moving Higher On Tuesday
Roivant Sciences, Pharvaris, IonQ And Other Big Stocks Moving Higher On Tuesday...
AAPL
Apple's Wednesday Event: Pricier iPhone 18 Pros and a $2,099 Foldable Expected
Apple's Wednesday Event: Pricier iPhone 18 Pros and a $2,099 Foldable Expected...
SPY
How To Trade SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, And TSLA
How To Trade SPY, QQQ, AAPL, MSFT, NVDA, GOOGL, META, And TSLA...
INTC
Northland Capital Markets Upgrades Intel to Outperform, Announces $120 Price Target
Northland Capital Markets Upgrades Intel to Outperform, Announces $120 Price Target...